Team

Dr. Nate Apathy, Assistant Professor of Health Policy & Management, studies how health information technology (IT) supports delivery and payment reform, how regulations shape IT innovation and use, and uses log data to assess IT’s impact on care quality. His current work examines IT‑related burden and ways to reduce it.

Dr. Baghdadi is an infectious disease physician, hospital epidemiologist, and health services researcher at the University of Maryland Medical Center – Midtown Campus. His clinical interests are infection prevention, antimicrobial stewardship, and early sepsis care. His research interests are diagnostic quality and safety, including diagnostic stewardship and diagnostic error.

Dr. Beckett is a computational ecologist and quantitative biologist studying virus dynamics and ecology. His work spans marine microbial ecology, network science, and infectious disease modeling, using computational and mathematical methods. He also advocates for Open Science and scientific transparency.

Dr. Bergman develops agent-based and mathematical models to investigate tumor-immune dynamics at the cell and tissue scale. His research integrates multiomics data to ground simulations in biological reality, with the goal of informing therapeutic interventions and advancing precision oncology.

Dr. Borda’s research spans biogeographical regions from the Central Andes to the African Great Lakes, integrating archaeology, anthropology, and genetics to study how evolutionary and demographic forces shape human diversity. Dr. Borda examines Native American gene flow and uses statistical genetics to understand recent Latin American population dynamics.

Michel Boudreaux is an Associate Professor in the Department of Health Policy and Management. He conducts research in interrelated areas of health policy. He is especially interested in public programs for low-income populations and their effects on health and economic well-being.

Dr. Breman’s work is aimed at improving care for individuals throughout pregnancy, labor, and birth via improved communication and respectful maternal care and by using a lens of reproductive justice as a guide. 

Jordan Broutman is the Director of Development for the University Corporate Relations (UCR) office. He works on strengthening and expanding campus-wide strategic corporate partnerships. The UCR office is responsible for expanding corporate gifts and grants that provide critical support to graduate education, faculty research, and priority campus initiatives.

Dr. Brown is a biostatistician and Associate Professor in Epidemiology and Public Health, and Director of the Biostatistics Unit in the VA Capitol Healthcare Network MIRECC. He collaborates widely across medicine, epidemiology, health services, and behavioral research.

Dr. Chixiang Chen, an NIH‑funded Associate Professor of Biostatistics, works across theory and applied statistics. He collaborates in trials and studies using claims, EHR, imaging, and oncology data. His research advances methods for causal inference, data integration, clustering, longitudinal and missing data, and biological age.

Dr. Jie Chen is Professor and Chair of the Department of Health Policy and Management at the University of Maryland School of Public Health. Her research incorporates artificial intelligence to examine system resilience, support caregivers, improve cost outcomes, and strengthen aging care.

Dr. Shuo Chen, an MPower Professor of Biostatistics and Bioinformatics, studies complex biomedical data, including neuroimaging, genetics, and omics graphs. He develops ML methods for individual‑level inference and collaborates widely across clinical, environmental, infectious disease, and cancer research.

Dr. Kevin Cullen is a leading head and neck oncologist and former director of the UM Greenebaum Cancer Center, which is ranked as one of the nation’s top cancer programs. His lab studies chemotherapy resistance, key biomarkers, and first identified racial survival disparities.

Warren D. D’Souza, PhD, MBA, is co-Director of the UM Institute for Health Computing and Professor and Division Head of Medical Physics in Radiation Oncology. He holds six U.S. patents and has served as principal investigator on multiple NIH, NSF, and industry‑funded grants.

Dr. Davis is a board‑certified family physician and NIH‑funded researcher focused on obesity‑related maternal and child health and comparative effectiveness in maternal health and tobacco use. Her work examines perinatal drivers of obesity and inequities affecting women’s long‑term cardiovascular health

Dr. Christopher deFilippi, Professor of Medicine and Pathology, specializes in cardiac biomarker discovery, validation, and clinical application. He has 300+ publications, NIH and industry funding, and extensive experience leading biomarker trials and developing FDA‑cleared assays.”

Florence (Flo) Doo, MD, MA, CIIP, is an abdominal radiologist, clinical informaticist, and physician innovator. She directs innovation at UM2ii and co‑leads AI‑enabled imaging research at the UM‑IHC. Her work spans imaging, AI, informatics, education, and responsible clinical translation.

Najib M. El‑Sayed is a professor of cell biology and molecular genetics with an appointment in UMIACS. His research applies genomics and bioinformatics to study parasitism and host–pathogen interactions, aiming to improve diagnosis, prevention, and treatment of parasitic and bacterial diseases.

Cornelia Fermüller is a research scientist in the UMIACS Computer Vision Lab. Her work spans computer and human vision, developing computational models for navigation, motion, and image processing. She studies visual motion, shape recovery, and builds cognitive robotic systems linking perception, action, and reasoning

Dr. Fertig develops predictive oncology by merging systems biology, multi‑omics, AI, and mathematical modeling. A leader in spatial omics and matrix factorization, she drives translational team‑science and leads major genomics and quantitative science initiatives at UMB.

Dr. Goodman applies informatics and AI, including NLP and LLMs, to large‑scale health record and claims data across infectious disease, oncology, and maternal‑fetal medicine. Dr. Goodman also studies legal oversight of clinical algorithms and emerging medical AI technologies.

Rebecca Gourevitch is a health services researcher using quantitative methods to study policies that impact access to affordable, high quality health care in the United States. Her work focuses on how to improve care and social support services for pregnant and postpartum individuals.

Dr. Abba Gumel uses mathematical modeling, analysis, and data analytics to study the transmission and control of emerging infectious diseases. His work in nonlinear dynamical systems and population biology supports effective public‑health policy and advances computational epidemiology.

Junfeng Guo is a postdoctoral associate at UMIACS working with Heng Huang. His research spans deep learning, computer vision, and privacy/security, focusing on improving AI systems’ security, privacy, and practical reliability.